Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Receivables - Other (2016 - 2021)

Historic Receivables - Other for iBio (IBIO) over the last 6 years, with Q1 2021 value amounting to $1000.0.

  • iBio's Receivables - Other changed N/A to $1000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $122000.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q1 2021, iBio's Receivables - Other is $1000.0.
  • iBio's Receivables - Other's 5-year high stood at $15.0 million during Q3 2017, with a 5-year trough of $1000.0 in Q1 2021.
  • For the 3-year period, iBio's Receivables - Other averaged around $9.0 million, with its median value being $15.0 million (2017).
  • As far as peak fluctuations go, iBio's Receivables - Other soared by 2409354.84% in 2017, and later changed by 0.0% in 2018.
  • Quarter analysis of 3 years shows iBio's Receivables - Other stood at $15.0 million in 2017, then tumbled by 99.62% to $57000.0 in 2018, then crashed by 98.25% to $1000.0 in 2021.
  • Its Receivables - Other was $1000.0 in Q1 2021, compared to $57000.0 in Q4 2018 and $15.0 million in Q3 2018.